Morel E, Vernet-der Garabedian B, Raimond F, Audhya T K, Goldstein G, Bach J F
Eur J Immunol. 1987 Aug;17(8):1109-13. doi: 10.1002/eji.1830170806.
The thymic hormone, thymopoietin (Tpo), from human (HTpo), bovine (BTpo) and from synthetic (sHTpo) origins bound to the acetylcholine receptor (AChR) solubilized by Triton 1.5% from human muscle. This binding was demonstrated either by inhibition of formation of radiolabeled alpha bungarotoxin (alpha Bgt)-AChR complexes measured after precipitation by ammonium sulfate or by a myasthenic serum containing a high concentration of anti-AChR antibodies, or directly by incubating the human AChR with radiolabeled sHTpo or BTpo. The 125I-labeled alpha Bgt-AChR complexes were totally inhibited by 10(-6) M sHTpo or BTpo. The complexes formed by AChR and the radiolabeled Tpo were recognized specifically by sera containing anti-AChR antibodies from myasthenic patients. The active pentapeptide derivative of Tpo, thymopentin, another thymic hormone, thymulin, as well as bovine insulin did not interfere with the specific binding of alpha Bgt to human AChR. Tpo and anti-AChR antibodies could participate together in the inhibition of neuromuscular conduction with Tpo modulating the depressive effect of the antibodies on the neuromuscular junction in myasthenia gravis.
来自人源(HTpo)、牛源(BTpo)和合成源(sHTpo)的胸腺激素胸腺生成素(Tpo)与用1.5% Triton从人肌肉中溶解的乙酰胆碱受体(AChR)结合。这种结合可通过抑制硫酸铵沉淀后测量的放射性标记α-银环蛇毒素(αBgt)-AChR复合物的形成来证明,也可通过含有高浓度抗AChR抗体的重症肌无力血清来证明,或者直接通过将人AChR与放射性标记的sHTpo或BTpo孵育来证明。10(-6) M的sHTpo或BTpo可完全抑制125I标记的αBgt-AChR复合物。AChR与放射性标记的Tpo形成的复合物可被来自重症肌无力患者的含有抗AChR抗体的血清特异性识别。Tpo的活性五肽衍生物胸腺五肽、另一种胸腺激素胸腺素以及牛胰岛素均不干扰αBgt与人AChR的特异性结合。Tpo和抗AChR抗体可能共同参与神经肌肉传导的抑制,其中Tpo可调节抗体对重症肌无力神经肌肉接头的抑制作用。